Sign In
Buy ATAI
$4.53
-0.280 (-5.82%)
At Close: Jun 03, 2026
atai Life Sciences and Beckley Psytech secure FDA Breakthrough Therapy Designation for BPL-003 in treatment-resistant depression
12:38pm, Thursday, 16'th Oct 2025
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) and Beckley Psytech announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy...
Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside
02:21pm, Monday, 13'th Oct 2025
Needham on Monday initiated coverage on Atai Life Sciences NV (NASDAQ:ATAI), a clinical-stage biopharmaceutical company focused on developing treatments for mental health.
atai Life Sciences' Glenn Short discusses the company's NIH grant and innovative discovery program – ICYMI
05:19pm, Friday, 03'rd Oct 2025
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) chief scientific officer Glenn Short spoke with Proactive about the company's recent NIH grant and its innovative discovery program targeting opioid use dis
Atai Life Sciences: Still A Decent Prospect - But Only Just
02:40pm, Wednesday, 01'st Oct 2025
Atai Life Sciences N.V. has surged >275% YTD, driven by promising psychedelic drug candidates targeting treatment-resistant depression and other mental health disorders. ATAI's lead asset, BPL-003, sh
Why Atai Life Sciences Stock Crushed It on Tuesday
05:51pm, Tuesday, 23'rd Sep 2025
Atai Life Sciences (ATAI 14.96%), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15% that
Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients
02:50pm, Tuesday, 23'rd Sep 2025
Atai Life Sciences ATAI and Beckley Psytech Limited, a private clinical-stage biopharmaceutical company, released data from a proof-of-concept study investigating a two-dose induction regimen of BPL-0
atai shares jump 10% on positive trial data for depression nasal spray
11:35am, Tuesday, 23'rd Sep 2025
Shares in atai Life Sciences (NASDAQ:ATAI, ETR:9VC) rose 10% on Tuesday after the company and its UK partner Beckley Psytech reported encouraging mid-stage trial results for their experimental nasal
atai Life Sciences and Beckley Psytech report positive mid-stage trial results for depression treatment
07:47am, Tuesday, 23'rd Sep 2025
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) and Beckley Psytech said Tuesday that their experimental nasal spray for depression showed promising results in a mid-stage clinical trial, bolstering hopes f
NEW YORK and AMSTERDAM and OXFORD, United Kingdom, Sept. 23, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company on a mission to develop
Are Medical Stocks Lagging atai Life Sciences (ATAI) This Year?
10:40am, Friday, 19'th Sep 2025
Here is how atai Life Sciences N.V. (ATAI) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.
atai Life Sciences secures NIH grant for opioid use disorder program
08:52am, Thursday, 18'th Sep 2025
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) announced that it has been awarded a grant of up to $11.4 million from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health
atai Life Sciences (ATAI) Upgraded to Buy: Here's What You Should Know
01:01pm, Thursday, 11'th Sep 2025
atai Life Sciences (ATAI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Atai Life Sciences N.V. (ATAI) Presents at H.C.
06:59am, Tuesday, 09'th Sep 2025
Atai Life Sciences N.V. (NASDAQ:ATAI ) H.C.
atai Life Sciences to Participate in September Investor Conferences
04:05pm, Thursday, 28'th Aug 2025
NEW YORK and AMSTERDAM, Aug. 28, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly eff
Here's Why atai Life Sciences (ATAI) Is a Great 'Buy the Bottom' Stock Now
10:56am, Monday, 18'th Aug 2025
atai Life Sciences (ATAI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement a
